𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer

✍ Scribed by Anita Koushik; Gregory J. Tranah; Jing Ma; Meir J. Stampfer; Howard D. Sesso; Charles S. Fuchs; Edward L. Giovannucci; David J. Hunter

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
98 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A single nucleotide polymorphism (SNP) at codon 72 of the p53 gene (Arg72Pro) alters the p53 protein structure and affects its activity. We investigated this SNP in relation to colorectal adenoma and cancer among men and women from case–control studies nested within the Nurses' Health Study, the Health Professionals Follow‐up Study and the Physicians' Health Study. Among 856 colorectal adenoma cases and 1,184 controls, we observed a modest association with p53 Arg72Pro genotype (multivariate odds ratio (OR) = 1.25, 95% confidence interval (CI) = 1.04–1.50 for Arg/Pro and Pro/Pro vs. Arg/Arg). This association did not vary by colorectal site or by sex. Among 442 colorectal cancer cases and 904 controls, we observed no significant overall association between p53 Arg72Pro genotype and colorectal cancer (multivariate OR = 1.14, 95% CI = 0.90–1.45). However, when colorectal site and sex was accounted for, the Pro carrier genotypes compared to Arg/Arg were associated with an increased risk of proximal colon cancers in women (multivariate OR = 2.59, 95% CI = 1.49–4.52) though not with distal colon or rectal cancers, while among men the same genotypes were associated with an increased risk of distal colon cancers (multivariate OR = 2.09, 95% CI = 1.28–3.40) but not proximal colon or rectal cancers. Our results suggest that Arg72Pro may play a role in the early stages of colorectal neoplasia and possibly in progression to invasive disease, depending on site and sex. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

TP53 Arg72Pro polymorphism and lung canc
TP53 Arg72Pro polymorphism and lung cancer risk: A meta-analysis
✍ Lili Yan; Deqiang Zhang; Chengwen Chen; Yumin Mao; Yi Xie; Yao Li; Yan Huang; Ba 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 461 KB 👁 1 views

## Abstract No clear consensus has been reached on the __TP53__ Arg72Pro polymorphism (G12139C) and lung cancer risk. Thus, a meta‐analysis was conducted to summarize the possible association. There was no statistical association between 12139C (Pro allele) and lung cancer risk in Caucasians compar

Association between TP53 gene ARG72PRO p
Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers
✍ Nicolay V. Litviakov; Evgeny V. Denisov; Ravil' M. Takhauov; Andrey B. Karpov; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

## Abstract It is well known that the TP53 gene considerably influences on DNA repair processes. Polymorphisms in the TP53 gene, particularly the well‐known Arg72Pro in codon 72 of exon 4 (Ex4+119 G>C; rs1042522), can modify the functionality of the p53 protein and activation of DNA repair. Actuall

A haplotype containing the p53 polymorph
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers
✍ A. Osorio; B. Martínez-Delgado; M. Pollán; M. Cuadros; M. Urioste; C. Torrentera 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Communicated by Dvorah Abeliovich Germline mutations in the BRCA1 and BRCA2 genes confer a high lifetime risk of developing breast and other cancers; however, remarkable differences exist regarding disease manifestation in mutation carriers. It has been suggested that other genetic and/or enviro

Arg72Pro TP53 polymorphism and cancer su
Arg72Pro TP53 polymorphism and cancer susceptibility: A comprehensive meta-analysis of 302 case-control studies
✍ Guilherme Francisco; Paulo Rossi Menezes; José Eluf-Neto; Roger Chammas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 1 views

## Abstract Arg72Pro is a common polymorphism in __TP53,__ showing differences in its biological functions. Case‐control studies have been performed to elucidate the role of Arg72Pro in cancer, although the results are conflicting and heterogeneous. Here, we analyzed pooled data from case‐control s

Combination of p53 codon 72 polymorphism
Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer
✍ Toshiji Tominaga; Makoto Iwahashi; Katsunari Takifuji; Tsukasa Hotta; Shozo Yoko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 272 KB

## Abstract There are increasing reports showing the clinical significance of the __p53__ polymorphism status in terms of the response to chemotherapy. We investigated whether __p53__ polymorphism and mutation were associated with __in vitro__ sensitivity to 5‐fluorouracil (5‐FU) in patients with c

The p53 codon 72 polymorphism, sunburns,
The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US caucasian women
✍ Jiali Han; David G. Cox; Graham A. Colditz; David J. Hunter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 1 views

## Abstract The p53 gene is involved in the control of cell‐cycle arrest and apoptosis. The germline Arg72Pro polymorphism alters the protein's biochemical functions, and may confer individual susceptibility to skin cancer. We evaluated the association of the Arg72Pro polymorphism with skin cancer